Soleus Capital
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$129.1M
Focus Areas
1
Top Stage
Phase IIa
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Heidelberg Pharma | $129.1M |
| Parse Biosciences | — |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Heidelberg Pharma | $129.1M |
| Parse Biosciences | — |